Epigenetic mechanisms in mood disorders: targeting neuroplasticity
about
DNA methylation, early life environment, and health outcomesGlia in the cytokine-mediated onset of depression: fine tuning the immune responseVisualizing epigenetics: current advances and advantages in HDAC PET imaging techniquesDifferential Expression of FosB Proteins and Potential Target Genes in Select Brain Regions of Addiction and Depression PatientsBrain plasticity-based therapeuticsIn vivo imaging of histone deacetylases (HDACs) in the central nervous system and major peripheral organs.Epigenetic Activation of ASCT2 in the Hippocampus Contributes to Depression-Like Behavior by Regulating D-Serine in Mice.The social brain meets the reactive genome: neuroscience, epigenetics and the new social biology.PET imaging demonstrates histone deacetylase target engagement and clarifies brain penetrance of known and novel small molecule inhibitors in rat.Class I HDAC imaging using [ (3)H]CI-994 autoradiographyFDG-PET imaging reveals local brain glucose utilization is altered by class I histone deacetylase inhibitors.Epigenetics across the human lifespan.Pathogenesis of depression: Insights from human and rodent studies.Immune signatures and disorder-specific patterns in a cross-disorder gene expression analysis.Translation: screening for novel therapeutics with disease-relevant cell types derived from human stem cell models.Advancing drug discovery for neuropsychiatric disorders using patient-specific stem cell models.Dissecting structure-activity-relationships of crebinostat: Brain penetrant HDAC inhibitors for neuroepigenetic regulation.Genome-wide association studies in pharmacogenomics of antidepressants.Environmental toxicants, incidence of degenerative diseases, and therapies from the epigenetic point of view.Histone and DNA Modifications as Regulators of Neuronal Development and Function.Toward development of epigenetic drugs for central nervous system disorders: Modulating neuroplasticity via H3K4 methylation.The APOE Gene is Differentially Methylated in Alzheimer's Disease.Epigenetic regulation of motivated behaviors by histone deacetylase inhibitors.The Importance of Non-neuronal Cell Types in hiPSC-Based Disease Modeling and Drug Screening.Epigenetic therapies - a new direction in clinical medicine.
P2860
Q26783146-31DDEA09-FACE-4956-960D-854B49B0ED4CQ26798929-12512DC0-4322-4D5A-B937-8896780705D7Q26862755-6FF389A4-71C5-4307-83C0-1E9568972A12Q28553391-76809C5B-9113-44AF-9C0C-141EA61BC1D7Q30435021-78C2B32C-5B2C-4360-9760-A42D75F7087EQ30591009-6CE8C9C2-DEBA-473E-89D5-C821D95B4E0BQ33650476-F0D71E9A-1660-45A1-A637-505DDD98C3F8Q33659365-D946F3C2-4377-4507-B739-F75D02BE336FQ34343350-32514D3F-E654-4EFA-9392-B07703FD656EQ34353711-18934D7E-439A-4595-9A29-EAB9B4FEE734Q34354229-31580B66-C6A7-4EB3-B9E4-09A67384136AQ34391404-CC30B7BA-67E2-4FFC-99A9-3F21307ED521Q36332597-4045668A-8800-4D38-B646-82D62628BE9CQ37223293-40F36C7D-61FD-4028-9717-BBB19E87BBC4Q37275071-83CCD6CB-3E25-4535-9CB1-2C7C3DA11484Q37624658-562D8FEF-9F1B-461A-B14D-04658C30541CQ38418571-27686C0E-29B2-4D5F-8713-96E1DA48C89BQ38444447-749B0158-628D-4979-A659-D0DC08532554Q38682574-199A894A-58AE-422E-9ADC-566C818D11BCQ38883999-BEA15624-0FFD-4376-89E6-FF86AD838E89Q38916715-0C37183D-32B4-45F3-8D21-B4F159082E4CQ40506926-1FC40581-A167-4F3B-A460-A009C368385FQ47315020-4B2C95D0-0627-48AA-AE8D-201F25A8F972Q47875785-A8E01C69-6FA1-4E36-BDBE-3077E2873792Q51733858-78474758-7809-410D-ACC7-7D6382F858BD
P2860
Epigenetic mechanisms in mood disorders: targeting neuroplasticity
description
2014 nî lūn-bûn
@nan
2014 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Epigenetic mechanisms in mood disorders: targeting neuroplasticity
@ast
Epigenetic mechanisms in mood disorders: targeting neuroplasticity
@en
Epigenetic mechanisms in mood disorders: targeting neuroplasticity
@nl
type
label
Epigenetic mechanisms in mood disorders: targeting neuroplasticity
@ast
Epigenetic mechanisms in mood disorders: targeting neuroplasticity
@en
Epigenetic mechanisms in mood disorders: targeting neuroplasticity
@nl
prefLabel
Epigenetic mechanisms in mood disorders: targeting neuroplasticity
@ast
Epigenetic mechanisms in mood disorders: targeting neuroplasticity
@en
Epigenetic mechanisms in mood disorders: targeting neuroplasticity
@nl
P2093
P2860
P3181
P1433
P1476
Epigenetic mechanisms in mood disorders: targeting neuroplasticity
@en
P2093
F.A. Schroeder
R.H. Perlis
S.J. Haggarty
P2860
P304
P3181
P356
10.1016/J.NEUROSCIENCE.2013.01.041
P407
P577
2014-04-04T00:00:00Z